Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Bio-Key International Inc’s stock clocked out at $0.77, down -15.13% from its previous closing price of $0.91. In other words, the price has decreased by -$15.13 from its previous closing price. On the day, 2.0 million shares were traded. BKYI stock price reached its highest trading level at $0.8569 during the session, while it also had its lowest trading level at $0.76.
Ratios:
To gain a deeper understanding of BKYI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.05 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.01.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BKYI now has a Market Capitalization of 5285794 and an Enterprise Value of 3644786. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.77 while its Price-to-Book (P/B) ratio in mrq is 0.77. Its current Enterprise Value per Revenue stands at 0.527 whereas that against EBITDA is -1.147.
Stock Price History:
The Beta on a monthly basis for BKYI is 0.45, which has changed by -0.37903225 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, BKYI has reached a high of $3.68, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -0.23%, while the 200-Day Moving Average is calculated to be -14.54%.
Shares Statistics:
It appears that BKYI traded 4.34M shares on average per day over the past three months and 27713940 shares per day over the past ten days. A total of 6.85M shares are outstanding, with a floating share count of 5.64M. Insiders hold about 17.77% of the company’s shares, while institutions hold 1.24% stake in the company. Shares short for BKYI as of 1760486400 were 20156 with a Short Ratio of 0.00, compared to 1757894400 on 33623. Therefore, it implies a Short% of Shares Outstanding of 20156 and a Short% of Float of 0.3.
Earnings Estimates
Its stock is currently analyzed by 1.0 different market analysts. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.5 and -$0.5 for the fiscal current year, implying an average EPS of -$0.5. EPS for the following year is -$0.32, with 1.0 analysts recommending between -$0.32 and -$0.32.
Revenue Estimates
In. The current quarter, 1 analysts expect revenue to total $1.8M. It ranges from a high estimate of $1.8M to a low estimate of $1.8M. As of. The current estimate, Bio-Key International Inc’s year-ago sales were $2.14MFor the next quarter, 1 analysts are estimating revenue of $2.2M. There is a high estimate of $2.2M for the next quarter, whereas the lowest estimate is $2.2M.
A total of 1 analysts have provided revenue estimates for BKYI’s current fiscal year. The highest revenue estimate was $7.3M, while the lowest revenue estimate was $7.3M, resulting in an average revenue estimate of $7.3M. In the same quarter a year ago, actual revenue was $6.93MBased on 1 analysts’ estimates, the company’s revenue will be $9M in the next fiscal year. The high estimate is $9M and the low estimate is $9M.
